Point-of-Care Gastric Ultrasound to Identify a Full Stomach on a Diabetic Patient Taking a Glucagon-Like Peptide 1 Receptor Agonist

Laura Girón-Arango; Anahi Perlas

doi:10.1213/XAA.0000000000001751

Point-of-Care Gastric Ultrasound to Identify a Full Stomach on a Diabetic Patient Taking a Glucagon-Like Peptide 1 Receptor Agonist

A A Pract. 2024 Feb 2;18(2):e01751. doi: 10.1213/XAA.0000000000001751. eCollection 2024 Feb 1.

Authors

Laura Girón-Arango^{1

2}, Anahi Perlas^{1

2}

Affiliations

¹ From the Department of Anesthesia and Pain Management, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
² Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario , Canada.

PMID: 38305719
DOI: 10.1213/XAA.0000000000001751

Abstract

Recently, there has been increased interest in the relationship between glucagon-like peptide 1 (GLP-1) receptor agonists, delayed gastric emptying, and subsequent risk of aspiration in the perioperative setting. This case illustrates how gastric ultrasound can be incorporated at the bedside to assess the risk of aspiration in patients taking this type of medication for diabetes or weight loss and guide clinical management and anesthetic technique to reduce the risk of aspiration.

Publication types

Case Reports

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Glucagon-Like Peptide-1 Receptor* / agonists
Humans
Hypoglycemic Agents* / adverse effects
Point-of-Care Systems
Stomach / diagnostic imaging

Substances

Hypoglycemic Agents
Glucagon-Like Peptide-1 Receptor